A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells

  • Authors:
    • Meiyan Shi
    • Xia Ren
    • Xidi Wang
    • Hengxiao Wang
    • Guoqiang Liu
    • Xiaofen Yuan
    • Shubo Zheng
    • Linchang Yu
    • Sufei Pan
    • Guanhua Song
    • Qiang Guo
    • Lianlian Li
    • Xiaoyu Zhang
    • Zhiyong Zhang
    • Huifang Ding
    • Guosheng Jiang
  • View Affiliations

  • Published online on: December 15, 2015     https://doi.org/10.3892/ijo.2015.3294
  • Pages: 734-746
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oridonin, obtained from the traditional Chinese herbal medicine rabdosia rubescens, exerts potent antitumor activities in cancer cells. Valproic acid (VPA), as a potent histone deacetylase inhibitor (HDACI), also plays an important role in inhibition of proliferation of tumor cells. However, there are no reports so far on the cooperation between oridonin and VPA for anti-leukemic effect. Therefore, in the present study, we undertook experiments to determine whether lower concentration of oridonin in conjunction with lower concentration of VPA would produce even more encouraging synergistic effect than each of them alone, and to clarify its molecular mechanism. The results demonstrated that the lower concentration of oridonin in combination with lower concentration of VPA synergistically inhibited the proliferation of HL-60 cells, and induced obvious caspase-dependent apoptosis through activation of the intrinsic apoptosis pathway, which is involved in the downregulation of Bcl-2/Bax ratio, release of cytochrome c to cytosol and caspase-9 activation, as well as through the extrinsic apoptosis pathway mediated by Fas/FasL and caspase-8 activation. In addition, MAPK signaling pathway was also involved in apoptosis induced by oridonin plus VPA. Furthermore, the combination treatment in vivo remarkably reduced the xenograft tumor size and triggered tumor cell apoptosis. Taken together, the novel combination of oridonin plus VPA exerted synergistic anti-proliferative and apoptosis-inducing effects on human myeloid leukemia cells, and may serve as a potential promising anti-leukemia strategy.
View Figures
View References

Related Articles

Journal Cover

February-2016
Volume 48 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shi M, Ren X, Wang X, Wang H, Liu G, Yuan X, Zheng S, Yu L, Pan S, Song G, Song G, et al: A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells. Int J Oncol 48: 734-746, 2016.
APA
Shi, M., Ren, X., Wang, X., Wang, H., Liu, G., Yuan, X. ... Jiang, G. (2016). A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells. International Journal of Oncology, 48, 734-746. https://doi.org/10.3892/ijo.2015.3294
MLA
Shi, M., Ren, X., Wang, X., Wang, H., Liu, G., Yuan, X., Zheng, S., Yu, L., Pan, S., Song, G., Guo, Q., Li, L., Zhang, X., Zhang, Z., Ding, H., Jiang, G."A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells". International Journal of Oncology 48.2 (2016): 734-746.
Chicago
Shi, M., Ren, X., Wang, X., Wang, H., Liu, G., Yuan, X., Zheng, S., Yu, L., Pan, S., Song, G., Guo, Q., Li, L., Zhang, X., Zhang, Z., Ding, H., Jiang, G."A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells". International Journal of Oncology 48, no. 2 (2016): 734-746. https://doi.org/10.3892/ijo.2015.3294